Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
Clinical trial NCT06586255 · RECRUITING
Trial details
- NCT number
- NCT06586255
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-29
- Primary completion
- 2027-04-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.